Natural Alternatives International Inc (NAII) stock
NAIINasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends June 30
$0.90−0.00 (-0.11%)
Close on Nov 18, 2026Market cap $19.90MP/E –Yield –
Natural Alternatives International total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Natural Alternatives International's total debt was $10.21M at Jun 30, 2026. For fiscal 2026 it was $10.21M, up 18.3% from the year before. The highest annual figure on record is $10.21M in fiscal 2026.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $10.21M | +18.3% |
| FY2025 | Jun 30, 2025 | $8.63M | -3.4% |
| FY2024 | Jun 30, 2024 | $8.93M | -3.0% |
| FY2023 | Jun 30, 2023 | $9.21M | -3.0% |
| FY2022 | Jun 30, 2022 | $9.49M | – |
| FY2021 | Jun 30, 2021 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $10.21M | +18.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $8.39M | -3.6% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $8.47M | -3.5% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $8.55M | -3.5% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $8.63M | -3.4% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $8.70M | -3.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $8.78M | -3.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $8.86M | -3.2% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $8.93M | -3.0% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $9.01M | -2.9% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $9.08M | -2.9% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $9.15M | -2.8% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $9.21M | -3.0% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $9.28M | -3.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $9.35M | -2.9% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $9.42M | -2.9% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $9.49M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $9.56M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $9.63M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $9.70M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $0 | – |
See a number that looks wrong?